Cargando…
Association of body mass index with disease severity and prognosis in patients with non-cystic fibrosis bronchiectasis
The objective of this observational, multicenter study was to evaluate the association of body mass index (BMI) with disease severity and prognosis in patients with non-cystic fibrosis bronchiectasis. A total of 339 patients (197 females, 142 males) diagnosed with non-cystic fibrosis bronchiectasis...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Associação Brasileira de Divulgação Científica
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541691/ https://www.ncbi.nlm.nih.gov/pubmed/26176309 http://dx.doi.org/10.1590/1414-431X20154135 |
_version_ | 1782386416276209664 |
---|---|
author | Qi, Q. Li, T. Li, J.C. Li, Y. |
author_facet | Qi, Q. Li, T. Li, J.C. Li, Y. |
author_sort | Qi, Q. |
collection | PubMed |
description | The objective of this observational, multicenter study was to evaluate the association of body mass index (BMI) with disease severity and prognosis in patients with non-cystic fibrosis bronchiectasis. A total of 339 patients (197 females, 142 males) diagnosed with non-cystic fibrosis bronchiectasis by high-resolution computed tomography were classified into four groups: underweight (BMI<18.5 kg/m(2)), normal weight (18.5≤BMI<25.0 kg/m(2)), overweight (25.0≤BMI<30.0 kg/m(2)), and obese (BMI≥30.0 kg/m(2)). Clinical variables expressing disease severity were recorded, and acute exacerbations, hospitalizations, and survival rates were estimated during the follow-up period. The mean BMI was 21.90 kg/m(2). The underweight group comprised 28.61% of all patients. BMI was negatively correlated with acute exacerbations, C-reactive protein, erythrocyte sedimentation rate, radiographic extent of bronchiectasis, and chronic colonization by P. aeruginosa and positively correlated with pulmonary function indices. BMI was a significant predictor of hospitalization risk independent of relevant covariates. The 1-, 2-, 3-, and 4-year cumulative survival rates were 94%, 86%, 81%, and 73%, respectively. Survival rates decreased with decreasing BMI (χ(2)=35.16, P<0.001). The arterial carbon dioxide partial pressure, inspiratory capacity, age, BMI, and predicted percentage of forced expiratory volume in 1 s independently predicted survival in the Cox proportional hazard model. In conclusion, an underweight status was highly prevalent among patients with non-cystic fibrosis bronchiectasis. Patients with a lower BMI were prone to developing more acute exacerbations, worse pulmonary function, amplified systemic inflammation, and chronic colonization by P. aeruginosa. BMI was a major determinant of hospitalization and death risks. BMI should be considered in the routine assessment of patients with non-cystic fibrosis bronchiectasis. |
format | Online Article Text |
id | pubmed-4541691 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Associação Brasileira de Divulgação Científica |
record_format | MEDLINE/PubMed |
spelling | pubmed-45416912015-09-02 Association of body mass index with disease severity and prognosis in patients with non-cystic fibrosis bronchiectasis Qi, Q. Li, T. Li, J.C. Li, Y. Braz J Med Biol Res Clinical Investigation The objective of this observational, multicenter study was to evaluate the association of body mass index (BMI) with disease severity and prognosis in patients with non-cystic fibrosis bronchiectasis. A total of 339 patients (197 females, 142 males) diagnosed with non-cystic fibrosis bronchiectasis by high-resolution computed tomography were classified into four groups: underweight (BMI<18.5 kg/m(2)), normal weight (18.5≤BMI<25.0 kg/m(2)), overweight (25.0≤BMI<30.0 kg/m(2)), and obese (BMI≥30.0 kg/m(2)). Clinical variables expressing disease severity were recorded, and acute exacerbations, hospitalizations, and survival rates were estimated during the follow-up period. The mean BMI was 21.90 kg/m(2). The underweight group comprised 28.61% of all patients. BMI was negatively correlated with acute exacerbations, C-reactive protein, erythrocyte sedimentation rate, radiographic extent of bronchiectasis, and chronic colonization by P. aeruginosa and positively correlated with pulmonary function indices. BMI was a significant predictor of hospitalization risk independent of relevant covariates. The 1-, 2-, 3-, and 4-year cumulative survival rates were 94%, 86%, 81%, and 73%, respectively. Survival rates decreased with decreasing BMI (χ(2)=35.16, P<0.001). The arterial carbon dioxide partial pressure, inspiratory capacity, age, BMI, and predicted percentage of forced expiratory volume in 1 s independently predicted survival in the Cox proportional hazard model. In conclusion, an underweight status was highly prevalent among patients with non-cystic fibrosis bronchiectasis. Patients with a lower BMI were prone to developing more acute exacerbations, worse pulmonary function, amplified systemic inflammation, and chronic colonization by P. aeruginosa. BMI was a major determinant of hospitalization and death risks. BMI should be considered in the routine assessment of patients with non-cystic fibrosis bronchiectasis. Associação Brasileira de Divulgação Científica 2015-07-10 /pmc/articles/PMC4541691/ /pubmed/26176309 http://dx.doi.org/10.1590/1414-431X20154135 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Investigation Qi, Q. Li, T. Li, J.C. Li, Y. Association of body mass index with disease severity and prognosis in patients with non-cystic fibrosis bronchiectasis |
title | Association of body mass index with disease severity and prognosis in
patients with non-cystic fibrosis bronchiectasis |
title_full | Association of body mass index with disease severity and prognosis in
patients with non-cystic fibrosis bronchiectasis |
title_fullStr | Association of body mass index with disease severity and prognosis in
patients with non-cystic fibrosis bronchiectasis |
title_full_unstemmed | Association of body mass index with disease severity and prognosis in
patients with non-cystic fibrosis bronchiectasis |
title_short | Association of body mass index with disease severity and prognosis in
patients with non-cystic fibrosis bronchiectasis |
title_sort | association of body mass index with disease severity and prognosis in
patients with non-cystic fibrosis bronchiectasis |
topic | Clinical Investigation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541691/ https://www.ncbi.nlm.nih.gov/pubmed/26176309 http://dx.doi.org/10.1590/1414-431X20154135 |
work_keys_str_mv | AT qiq associationofbodymassindexwithdiseaseseverityandprognosisinpatientswithnoncysticfibrosisbronchiectasis AT lit associationofbodymassindexwithdiseaseseverityandprognosisinpatientswithnoncysticfibrosisbronchiectasis AT lijc associationofbodymassindexwithdiseaseseverityandprognosisinpatientswithnoncysticfibrosisbronchiectasis AT liy associationofbodymassindexwithdiseaseseverityandprognosisinpatientswithnoncysticfibrosisbronchiectasis |